Exciting content will be coming soon to the Genetic Disorders channel, so stay tuned for more from Medical Crossfire™.

Pharma Industry / Biotech Industry

PhRMA Spends $6.3 Lobbying In Fourth Quarter, Slight Increase From Year Before
Fri, 12 Mar 2010 03:00:00 PST

Respiratory / Asthma

AstraZeneca Comments On FDA Joint Advisory Committee Meeting On Post-Marketing Safety Studies For The Use Of LABAs In Asthma
Fri, 12 Mar 2010 02:00:00 PST

Should the United States adopt a universal health coverage system similar to those in place in countries such as the United Kingdom and Canada? ( surveys)

The MedicalCrossfire.com Web site is designed and presented for education and information purposes only and not for the purpose of rendering medical advice. This Web site is not instructional for medical diagnosis or treatment and should not be used to determine a course of treatment for a particular individual nor as a substitute for competent medical treatment. The information presented is not exhaustive with regard to any disease, ailment, physical condition, or treatment. Medical Crossfire™ is not liable for the opinions and content expressed herein. See "Terms of Use" and "Privacy Policy".

Allergy and Immunology	Hematology/Oncology	Psychiatry
Cardiovascular	Infectious Diseases	Residents
College Health	Nephrology	Respiratory
Dermatology	Neurology	Rheumatology
Diabetes and Endocrinology	Obesity	Surgery
Gastroenterology	Pain Management	Urology
Genetic Disorders	Primary Care	Women's Health